These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 3923038)
21. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease]. Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 beta gene. Wewers MD; Saltini C; Sellers S; Tocci MJ; Bayne EK; Schmidt JA; Crystal RG Cell Immunol; 1987 Jul; 107(2):479-88. PubMed ID: 3297354 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. Hunninghake GW; Crystal RG J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734 [TBL] [Abstract][Full Text] [Related]
24. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. Agostini C; Cassatella M; Zambello R; Trentin L; Gasperini S; Perin A; Piazza F; Siviero M; Facco M; Dziejman M; Chilosi M; Qin S; Luster AD; Semenzato G J Immunol; 1998 Dec; 161(11):6413-20. PubMed ID: 9834133 [TBL] [Abstract][Full Text] [Related]
25. Fusion and activation of human alveolar macrophages induced by recombinant interferon-gamma and their suppression by dexamethasone. Nagasawa H; Miyaura C; Abe E; Suda T; Horiguchi M; Suda T Am Rev Respir Dis; 1987 Oct; 136(4):916-21. PubMed ID: 3116897 [TBL] [Abstract][Full Text] [Related]
26. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. Fireman E; Ben-Efraim S; Spinrad S; Topilsky M; Greif J Eur Respir J; 1993 Jul; 6(7):956-64. PubMed ID: 8370444 [TBL] [Abstract][Full Text] [Related]
28. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. Hunninghake GW; Gadek JE; Young RC; Kawanami O; Ferrans VJ; Crystal RG N Engl J Med; 1980 Mar; 302(11):594-8. PubMed ID: 6965420 [TBL] [Abstract][Full Text] [Related]
29. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. Konishi K; Moller DR; Saltini C; Kirby M; Crystal RG J Clin Invest; 1988 Sep; 82(3):775-81. PubMed ID: 3138285 [TBL] [Abstract][Full Text] [Related]
30. [Proliferation of alveolar macrophages in pulmonary sarcoidosis correlates with markers of lymphocyte activity in bronchoalveolar lavage fluid]. Barth J; Kreipe H; Kiemle-Kallee J; Radzun HJ; Petermann W Pneumologie; 1990 Feb; 44 Suppl 1():224-5. PubMed ID: 1973297 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxic activity of human pulmonary alveolar macrophages. Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151 [TBL] [Abstract][Full Text] [Related]
32. Influence of IFN-gamma on gene expression in normal human bronchial epithelial cells: modulation of IFN-gamma effects by dexamethasone. Pawliczak R; Logun C; Madara P; Barb J; Suffredini AF; Munson PJ; Danner RL; Shelhamer JH Physiol Genomics; 2005 Sep; 23(1):28-45. PubMed ID: 15985639 [TBL] [Abstract][Full Text] [Related]
33. Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. Jaffe HA; Buhl R; Mastrangeli A; Holroyd KJ; Saltini C; Czerski D; Jaffe HS; Kramer S; Sherwin S; Crystal RG J Clin Invest; 1991 Jul; 88(1):297-302. PubMed ID: 1905329 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. Bitterman PB; Adelberg S; Crystal RG J Clin Invest; 1983 Nov; 72(5):1801-13. PubMed ID: 6630527 [TBL] [Abstract][Full Text] [Related]
35. Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis. Moseley PL; Hemken C; Monick M; Nugent K; Hunninghake GW Chest; 1986 May; 89(5):657-62. PubMed ID: 3084179 [TBL] [Abstract][Full Text] [Related]
36. Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. Reichel H; Koeffler HP; Barbers R; Norman AW J Clin Endocrinol Metab; 1987 Dec; 65(6):1201-9. PubMed ID: 3119653 [TBL] [Abstract][Full Text] [Related]
37. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. Müller-Quernheim J; Saltini C; Sondermeyer P; Crystal RG J Immunol; 1986 Dec; 137(11):3475-83. PubMed ID: 3491139 [TBL] [Abstract][Full Text] [Related]
38. Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis. Balbi B; Moller DR; Kirby M; Holroyd KJ; Crystal RG J Clin Invest; 1990 May; 85(5):1353-61. PubMed ID: 2110187 [TBL] [Abstract][Full Text] [Related]